{
    "componentChunkName": "component---src-templates-blog-post-js",
    "path": "/posts/1142582e473711ecaae809e418393bd1/",
    "result": {"data":{"allMysqlLists":{"edges":[{"node":{"title":"Pfizer agrees to let other companies make its COVID-19 pill","status":1,"alt":"","src":"https://live-production.wcms.abc-cdn.net.au/255d5648d533fddcb6b1e850f4483acf","source":"abc","menu":"au","local_src":"","load_img":"","img_url":"https://live-production.wcms.abc-cdn.net.au/255d5648d533fddcb6b1e850f4483acf","href":"https://www.abc.net.au/news/2021-11-17/pfizer-agrees-to-let-other-companies-make-its-covid-19-pill/100626396","description":"Pfizer signs a deal with a UN-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world's population.","country":"au","create_time":"2021-11-16T15:44:13.000Z","content":"[\"Pfizer\\u00a0has signed a deal with a UN-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world's population.\", \"Pfizer said it would grant a licence for the antiviral pill to the Geneva-based Medicines Patent Pool.\", \"That will allow generic drug companies to produce the pill for use in 95 countries, covering about 53 per cent\\u00a0of the world's population.\", \"The experimental pill could be a promising new weapon in the fight against the pandemic, as it can be taken orally as an early at-home treatment to help prevent COVID-19 hospitalisations and deaths.\", \"In a clinical trial, it\\u00a0cut the chance of hospitalisation or death for adults at risk of severe disease by 89 per cent.\", \"It could also become a important tool in countries and areas with limited access to vaccines, or with low vaccination rates.\", \"<img src=\\\"https://live-production.wcms.abc-cdn.net.au/9ab9f0ac80b0acb7cc64441312c1ba3b\\\" class=\\\"abcImg\\\"></img>\", \"<div class=\\\"imgText\\\"> Fewer than 1 per cent\\u00a0of Pfizer's COVID-19 shots have gone to poorer countries.(AP:\\u00a0Guadalupe Pardo)</div>\", \"The multi-nation deal excludes some large countries that have suffered devastating coronavirus outbreaks.\", \"For example, while a Brazilian drug company can get a licence to make the pill for export to other countries, the medicine cannot\\u00a0be made generically for use in Brazil.\", \"Still, health officials said the fact that the deal was struck even before Pfizer's pill has been authorised anywhere, could help to end the pandemic quicker.\", \"He estimated that other drugmakers would be able to start producing the pill within months, but acknowledged the agreement wouldn't please everyone.\", \"\\\"We try to strike a very delicate balance between the interests of the (company), the sustainability required by generic producers and most importantly, the public health needs in lower and middle-income countries,\\\" Mr Burrone said.\", \"<div class=\\\"head3\\\">Pfizer seeking emergency use in US</div>\", \"<img src=\\\"https://live-production.wcms.abc-cdn.net.au/ca19195201644dfb30fd6caa5eb20e25\\\" class=\\\"abcImg\\\"></img>\", \"<div class=\\\"imgText\\\"> Pfizer has submitted\\u00a0its experimental pill for US\\u00a0authorisation.(AP)</div>\", \"Under the terms of the agreement, Pfizer will not receive royalties on sales in low-income countries and will waive royalties on sales in all countries covered by the agreement while COVID-19 remains a public health emergency.\", \"Pfizer said it had completed submission of its application for emergency use authorisation (EUA) of the drug, Paxlovid, with the US\\u00a0Food and Drug Administration.\", \"It is not immediately clear when US\\u00a0regulators will rule on Pfizer's application.\", \"Merck & Co and Ridgeback Biotherapeutics, which are developing a competing pill, molnupiravir, completed their EUA submission on October\\u00a011.\", \"A panel of outside advisers to the FDA will meet to consider that application on November\\u00a030. It is expected to be available in the US this year.\", \"\\\"We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients,\\\" Pfizer chief executive Albert Bourla said in a news release.\", \"<div class=\\\"head3\\\">The race to develop better\\u00a0COVID treatments</div>\", \"Since the pandemic erupted last year, researchers worldwide have raced to develop a pill to treat COVID-19 that can be taken at home easily to ease symptoms, speed recovery and keep people out of the hospital.\", \"At the moment, most COVID-19 treatments must be delivered intravenously or by injection.\", \"Britain authorised Merck's COVID-19 pill earlier this month, and it is pending approval elsewhere.\", \"In a similar deal with the Medicines Patent Pool announced in October, Merck agreed to let other drugmakers make\\u00a0molnupiravir\\u00a0available in 105 poorer countries.\", \"Doctors Without Borders said it was \\\"disheartened\\\" that the Pfizer deal would not make the drug available to the entire world, noting that the agreement excluded\\u00a0countries including China, Argentina and Thailand.\", \"\\\"The world knows by now that access to COVID-19 medical tools needs to be guaranteed for everyone, everywhere, if we really want to control this pandemic,\\\" said Yuanqiong Hu, a senior legal policy adviser at Doctors Without Borders.\", \"The decisions by Pfizer and Merck to share their COVID-19 drug patents stand\\u00a0in stark contrast to the refusal of Pfizer and other vaccine-makers to release their vaccines\\u00a0for wider production.\", \"A hub set up by the World Health Organization in South Africa to share vaccine recipes and technologies has not enticed a single pharmaceutical to join.\", \"Fewer than 1 per cent\\u00a0of Pfizer's COVID-19 shots have gone to poorer countries.\", \"ABC/wires\"]","href_hash":"1142582e473711ecaae809e418393bd1"}}]}},"pageContext":{"slug":"1142582e473711ecaae809e418393bd1"}},
    "staticQueryHashes": ["3649515864","764694655"]}